SlideShare uma empresa Scribd logo
1 de 1
Baixar para ler offline
press release
IBIS Technologies B.V. Discovery Summit 2013 at Le Méridien Beach Plaza, Monte-
Carlo, Monaco, 21-22 March 2013.

marcus evans is pleased to announce the participation of IBIS
Technologies as a Sponsor at the Discovery Summit 2013
taking place at Le Méridien Beach Plaza, Monte-Carlo, Monaco
21-22 March 2013.                                                 www.linkedin.com/groups?home=&gid
                                                                  =3529112&trk=anet_ug_hm
About the Summit
The Discovery Summit provides a unique and exclusive forum
for global R&D professionals and drug discovery sponsors to
focus in an intimate environment on discussions around key
new drivers shaping discovery research and development
                                                                  www.slideshare.net/MarcusEvansPhar
today. More details about the Discovery Summit 2013 can be
                                                                  ma
found here.

About the Company
IBIS Technologies is an analysis and instrumentation company
for label free and in depth monitoring of multiple biomolecular
                                                                  www.twitter.com/meSummitsPharma
interactions using array technology. IBIS Technologies is
developer and supplier of biosensor based analytical
instrumentation and consumables for the Life Science and R&D
markets. Our focus is to provide users with high end
instrumentation of uncompromised quality in combination
with lowest costs of ownership. www.ibis-spr.nl                   www.youtube.com/user/MarcusEvans
                                                                  Pharma

More Info
For further information on the Discovery Summit 2013 programme please contact
Ruth Abbott
Marketing PR & Communications Director
ruth.PRsummits@marcusevans.com
marcus evans

Mais conteúdo relacionado

Mais de Life Sciences Network marcus evans

Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...Life Sciences Network marcus evans
 
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...Life Sciences Network marcus evans
 
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...Life Sciences Network marcus evans
 
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Life Sciences Network marcus evans
 
Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...Life Sciences Network marcus evans
 
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...Life Sciences Network marcus evans
 
Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...Life Sciences Network marcus evans
 
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...Life Sciences Network marcus evans
 
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...Life Sciences Network marcus evans
 
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...Life Sciences Network marcus evans
 
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...Life Sciences Network marcus evans
 
CRTH2 Antagonists for the Treatment of Asthma and Allergic Rhinoconjunctivitis
CRTH2 Antagonists for the Treatment of Asthma and Allergic RhinoconjunctivitisCRTH2 Antagonists for the Treatment of Asthma and Allergic Rhinoconjunctivitis
CRTH2 Antagonists for the Treatment of Asthma and Allergic RhinoconjunctivitisLife Sciences Network marcus evans
 
Adopting a truly patient-centric strategy to find a cure for rare diseases
Adopting a truly patient-centric strategy to find a cure for rare diseasesAdopting a truly patient-centric strategy to find a cure for rare diseases
Adopting a truly patient-centric strategy to find a cure for rare diseasesLife Sciences Network marcus evans
 
The one-on-one meetings with potential customers is what matters most
The one-on-one meetings with potential customers is what matters mostThe one-on-one meetings with potential customers is what matters most
The one-on-one meetings with potential customers is what matters mostLife Sciences Network marcus evans
 
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...Life Sciences Network marcus evans
 
Achieving Realistic Project Timelines through Strategic Partnerships and Alli...
Achieving Realistic Project Timelines through Strategic Partnerships and Alli...Achieving Realistic Project Timelines through Strategic Partnerships and Alli...
Achieving Realistic Project Timelines through Strategic Partnerships and Alli...Life Sciences Network marcus evans
 

Mais de Life Sciences Network marcus evans (20)

Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
 
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
 
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
 
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
 
Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...
 
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
 
Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...
 
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
 
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
 
Business Development Activities Interview - Clinart MENA
Business Development Activities Interview - Clinart MENABusiness Development Activities Interview - Clinart MENA
Business Development Activities Interview - Clinart MENA
 
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
 
Where marcus evans fits in our business development mix
Where marcus evans fits in our business development mixWhere marcus evans fits in our business development mix
Where marcus evans fits in our business development mix
 
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
 
CRTH2 Antagonists for the Treatment of Asthma and Allergic Rhinoconjunctivitis
CRTH2 Antagonists for the Treatment of Asthma and Allergic RhinoconjunctivitisCRTH2 Antagonists for the Treatment of Asthma and Allergic Rhinoconjunctivitis
CRTH2 Antagonists for the Treatment of Asthma and Allergic Rhinoconjunctivitis
 
Grow Your Business
Grow Your BusinessGrow Your Business
Grow Your Business
 
What it Takes to Achieve a Successful Drug Discovery Alliance
What it Takes to Achieve a Successful Drug Discovery AllianceWhat it Takes to Achieve a Successful Drug Discovery Alliance
What it Takes to Achieve a Successful Drug Discovery Alliance
 
Adopting a truly patient-centric strategy to find a cure for rare diseases
Adopting a truly patient-centric strategy to find a cure for rare diseasesAdopting a truly patient-centric strategy to find a cure for rare diseases
Adopting a truly patient-centric strategy to find a cure for rare diseases
 
The one-on-one meetings with potential customers is what matters most
The one-on-one meetings with potential customers is what matters mostThe one-on-one meetings with potential customers is what matters most
The one-on-one meetings with potential customers is what matters most
 
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven...
 
Achieving Realistic Project Timelines through Strategic Partnerships and Alli...
Achieving Realistic Project Timelines through Strategic Partnerships and Alli...Achieving Realistic Project Timelines through Strategic Partnerships and Alli...
Achieving Realistic Project Timelines through Strategic Partnerships and Alli...
 

IBIS Technologies B.V. Discovery Summit 2013

  • 1. press release IBIS Technologies B.V. Discovery Summit 2013 at Le Méridien Beach Plaza, Monte- Carlo, Monaco, 21-22 March 2013. marcus evans is pleased to announce the participation of IBIS Technologies as a Sponsor at the Discovery Summit 2013 taking place at Le Méridien Beach Plaza, Monte-Carlo, Monaco 21-22 March 2013. www.linkedin.com/groups?home=&gid =3529112&trk=anet_ug_hm About the Summit The Discovery Summit provides a unique and exclusive forum for global R&D professionals and drug discovery sponsors to focus in an intimate environment on discussions around key new drivers shaping discovery research and development www.slideshare.net/MarcusEvansPhar today. More details about the Discovery Summit 2013 can be ma found here. About the Company IBIS Technologies is an analysis and instrumentation company for label free and in depth monitoring of multiple biomolecular www.twitter.com/meSummitsPharma interactions using array technology. IBIS Technologies is developer and supplier of biosensor based analytical instrumentation and consumables for the Life Science and R&D markets. Our focus is to provide users with high end instrumentation of uncompromised quality in combination with lowest costs of ownership. www.ibis-spr.nl www.youtube.com/user/MarcusEvans Pharma More Info For further information on the Discovery Summit 2013 programme please contact Ruth Abbott Marketing PR & Communications Director ruth.PRsummits@marcusevans.com marcus evans